Town Hall
Event Title
Virtual Town Hall Series - Coronavirus (COVID-19) Test Development and Validation
December 16, 2020
- Date:
- December 16, 2020
- Time:
-
12:15 PM - 1:15 PM ET
Tell us what you think about the town halls
Summary:
The U.S. Food and Drug Administration (FDA) will host a virtual Town Hall for SARS-CoV-2 test developers. The purpose of this Town Hall is to help answer technical questions about the development and validation of tests for SARS-CoV-2.
Add December dates to my Calendar
Outlook users: Click link, select Open, then click Save & Close
Background:
The FDA plays a critical role in protecting the United States from threats such as emerging infectious diseases, including the Coronavirus Disease 2019 (COVID-19) pandemic. The FDA is committed to providing timely guidance to support response efforts to this pandemic.
The immediately in effect guidance "Policy for Coronavirus Disease-2019 Tests During the Public Health Emergency (Revised)" includes policies specific to this public health emergency. This guidance was issued on February 29, 2020 and subsequently updated on March 16, 2020, May 4, 2020, and May 11, 2020.
Stakeholder Call Details:
Registration is not necessary.
Time: 12:15 p.m. - 1:15 p.m.
To ensure you are connected, please dial in 15 minutes prior to the start of the call.
U.S. Callers Dial:
- 888-455-1392
- Conference Number: RWXW1777650
- Passcode: 7068896
International Callers Dial:
- 1-773-799-3847
- Conference Number: RWXW1777650
- Passcode: 7068896
To view the slide presentation during the webinar:
https://www.mymeetings.com/nc/join.php?i=RWXW1777650&p=7068896&t=c
Following the webinar, a transcript, recoding, and slides will be posted below.
Previous Town Halls from the Immediately in Effect Guidance on Coronavirus (COVID-19) Diagnostic Tests Series